[1] Windahl SH, Norgard M, Kuiper GG, et al.Cellular distribution of estrogen rece ptor beta in neonatal rat bone. Bone.2000;26(2): 117-121.
[2] Shoukry A, Shalaby SM, Etewa RL, et al.Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women. Mol Cell Biochem.2015;405(1-2):23-31.
[3] Claros S, Rico-Llanos GA, Becerra J, et al. A novel human TGF-β1 fusion protein in combination with rhBMP-2 increases chondro-osteogenic differentiation of bone marrow mesenchymal stem cells. Int J Mol Sci. 2014;15(7):11255-11274.
[4] 邓盎, 张宏其, 郭超峰, 等.利用RNAi技术稳定抑制ERβ表达的人成骨细胞株hFOB 1.19细胞模型的建立[J].中国脊柱脊髓杂志, 2012, 22(8): 722-728.
[5] Nelson ER, Habibi HR.Estrogen receptor function and regulation in fish and other vertebrates. Gen Comp Endocrinol.2013;192:15-24.
[6] Vivar OI, Zhao X, Saunier EF, et al. Estrogen receptor beta binds to and regulates three distinct classes of target genes. J Biol Chem.2010;285(29): 22059-22066.
[7] Nott SL, Huang Y,Fluharty BR,et al.Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling? Curr Pharmacogenomics Person Med.2008;6(4): 239-259.
[8] Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal.2008;6: e003.
[9] Syed FA,Fraser DG,Monroe DG,et al.Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone. Bone.2011;49(2):208-216.
[10] Spelsberg TC, Subramaniam M, Riggs BL, et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol, 1999,13(6): 819-828.
[11] Syed FA, Mödder UI, Fraser DG, et al. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J Bone Miner Res.2005;20(11):1992-2001.
[12] Vico L, Vanacker JM. Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models. Osteoporos Int. 2010;21(3): 365-372.
[13] Windahl SH, Vidal O, Andersson G, et al. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest.1999;104(7): 895-901.
[14] Lindberg MK, Alatalo SL, Halleen JM, et al.Estrogen receptor specificity in the regulation of the skeleton in female mice.J Endocrinol,2001;171(2): 229-236.
[15] Sims NA, Dupont S, Krust A, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone.2002;30(1):18-25.
[16] Sims NA, Clément-Lacroix P, Minet D, et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest.2003;111(9): 1319-1327.
[17] Chagin AS, Lindberg MK, Andersson N, et al. Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J Bone Miner Res.2004;19(1): 72-77.
[18] Delaisse JM. The reversal phase of the bone-r emodeling cycle: cellular prerequisites for coupling resorption and formation. Bonekey Rep, 2014, 3:561.
[19] Soltanoff CS, Yang S, Chen W, et al. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr.2009; 19(1): 1-46.
[20] Gingery A, Bradley EW, Pederson L, et al.TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.Exp Cell Res.2008;314(15): 2725-2738.
[21] Yamada Y, Miyauchi A, Goto J, et al.Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res.1998;13(10): 1569-1576.
[22] Bosetti M, Boccafoschi F, Leigheb M, et al. Effect of different growth factors on human osteoblasts activities: a possible application in bone regeneration for tissue engineering. Biomol Eng.2007;24(6): 613-618.
[23] Jenner JM, van Eijk F, Saris DB, et al.Effect of transforming growth factor-beta and growth differentiation factor-5 on proliferation and matrix production by human bone marrow stromal cells cultured on braided poly lactic-co-glycolic acid scaffolds for ligament tissue engineering. Tissue Eng. 2007;13(7): 1573-1582.
[24] Xu Y, James AW, Longaker MT.Transforming growth factor-beta1 stimulates chondrogenic differentiation of posterofrontal suture-derived mesenchymal cells in vitro. Plast Reconstr Surg.2008;122(6): 1649-1659.
[25] Slater M, Patava J, Kingham K, et al. Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 beta-estradiol.Am J Physiol.1994;267(6 Pt 1): E990-1001.
[26] Hughes DE, Dai A, Tiffee JC, et al.Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med.1996;2(10): 1132-1136.
[27] Zhu S, Zhang T, Sun C, et al. Bone marrow mesenchymal stem cells combined with calcium alginate gel modified by hTGF-β1 for the construction of tissue-engineered cartilage in three-dimensional conditions. Exp Ther Med. 2013;5(1):95-101.
[28] DeLong WG Jr, Einhorn TA, Koval K, et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am.2007; 89(3): 649-658.
[29] Luu HH, Song WX, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res.2007; 25(5): 665-677.
[30] Hsu YL, Liang HL, Hung CH, et al. Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway. Mol Nutr Food Res. 2009;53(11): 1452-1461.
[31] Zoricic S, Maric I, Bobinac D, et al. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat.2003;202(Pt 3): 269-277.
[32] Huang W,Rudkin GH,Carlsen B,et al.Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells. Exp Cell Res. 2002; 274(2):226-234.
[33] Sun J, Li J, Li C, et al. Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells. Mol Med Rep.2015;12(3):4230-4237.
[34] Hertrampf T, Gruca MJ, Seibel J, et al.The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity. Bone.2007; 40(6):1529-1535.
[35] Lindberg MK,Movérare S,Eriksson AL,et al. Identification of estrogen-regulated genes of potential importance for the regulation of trabecular bone mineral density.J Bone Miner Res.2002;17(12): 2183-2195.
[36] Monroe DG, Getz BJ, Johnsen SA, et al. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.J Cell Biochem. 2003;90(2):315-326.
[37] 王昱翔,张宏其,郭超峰,等. 雌激素受体β基因沉默对成骨样MG63细胞骨保护素和RANKL表达的影响[J]. 中国组织工程研究, 2013, 17(41):7188-7198.
[38] 王昱翔,张宏其,郭超峰,等.人雌激素β受体RNAi反转录病毒载体在人成骨样MG63细胞中的表达[J].中国组织工程研究, 2012,16(42):7830-7836.
[39] 鲁世金,张宏其,高其乐,等. 雌激素受体基因ERβ与小鼠成骨细胞的增殖和分化[J].中国组织工程研究与临床康复,2011,15(28):5157-5160.
[40] 白旭华.雌激素受体与绝经后骨质疏松症[J].中国组织工程研究与临床康复, 2008, 12(37):7398-7400. |